ATYR 8-K 2026-10-16

aTYR PHARMA INC (ATYR) 8-K dated 2026-10-16 — accession 0001339970-26-000068. This URL is the filing, not the ATYR hub.

aTYR PHARMA INC (ATYR) is a biotechnology company listed on US.

aTYR PHARMA INC filed a 8-K on 2026-10-16. Accession 0001339970-26-000068.

Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ATYR revenue for 2025-12-31 was $190.0K. Net income was -$74.1M. Revenue was down 19.1% from 2024-12-31 to 2025-12-31. ATYR currently screens at market cap $471.7M.

Not investment advice. The ATYR SEC hub lists recent forms. The stock page is the research view.